Raja C Pullatt1, Mamatha Reddy Gadarla, Richard H Karas
1Department of Internal Medicine, University of Connecticut, Farmington, Connecticut, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Simvastatin and ezetimibe (Vytorin) may increase the risk of tendon rupture. These cholesterol drugs might alter matrix metalloproteinase activity, hindering tendon repair and increasing injury likelihood.
Area of Science:
Background:
Observation:
Findings:
Implications: